Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Whole exome sequencing to identify genetic markers for trastuzumab-induced cardiotoxicity.

Udagawa C, Nakamura H, Ohnishi H, Tamura K, Shimoi T, Yoshida M, Yoshida T, Totoki Y, Shibata T, Zembutsu H.

Cancer Sci. 2018 Feb;109(2):446-452. doi: 10.1111/cas.13471. Epub 2018 Jan 24.

2.

Targeted Nanomaterials for Phototherapy.

Chitgupi U, Qin Y, Lovell JF.

Nanotheranostics. 2017 Jan 1;1(1):38-58. doi: 10.7150/ntno.17694. eCollection 2017. Review.

3.
5.

Novel paradigm for immunotherapy of breast cancer by engaging prophylactic immunity against hepatitis B.

Malecki M, Sabo C, Foorohar A, Tombokan X.

Clin Transl Med. 2016 Dec;5(1):32. doi: 10.1186/s40169-016-0111-8. Epub 2016 Aug 18.

6.

Targeted Reconstitution of Cytokine Activity upon Antigen Binding using Split Cytokine Antibody Fusion Proteins.

Venetz D, Koovely D, Weder B, Neri D.

J Biol Chem. 2016 Aug 26;291(35):18139-47. doi: 10.1074/jbc.M116.737734. Epub 2016 Jul 8.

14.
15.

Therapeutic Considerations in Treating HER2-Positive Metastatic Breast Cancer.

O'Sullivan CC, Smith KL.

Curr Breast Cancer Rep. 2014 Sep 1;6(3):169-182.

16.

HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer.

Green AR, Barros FF, Abdel-Fatah TM, Moseley P, Nolan CC, Durham AC, Rakha EA, Chan S, Ellis IO.

Breast Cancer Res Treat. 2014 May;145(1):33-44. doi: 10.1007/s10549-014-2925-7. Epub 2014 Apr 6.

17.

Effects of hormonotherapy administered after concurrent radiotherapy and Trastuzumab on pulmonary fibrosis.

Benderli Cihan Y, Deniz K, Mutlu H, Kaplan B.

Hippokratia. 2013 Jul;17(3):228-32.

18.

Heparan sulfate mediates trastuzumab effect in breast cancer cells.

Suarez ER, Paredes-Gamero EJ, Del Giglio A, Tersariol IL, Nader HB, Pinhal MA.

BMC Cancer. 2013 Oct 1;13:444. doi: 10.1186/1471-2407-13-444.

19.

From bench to bedside: lessons learned in translating preclinical studies in cancer drug development.

Lieu CH, Tan AC, Leong S, Diamond JR, Eckhardt SG.

J Natl Cancer Inst. 2013 Oct 2;105(19):1441-56. doi: 10.1093/jnci/djt209. Epub 2013 Sep 19. Review.

20.

New developments in the treatment of HER2-positive breast cancer.

Nahta R.

Breast Cancer (Dove Med Press). 2012 May 1;4:53-64.

Supplemental Content

Support Center